Bessemer Group Inc. lowered its position in shares of CME Group Inc (NASDAQ:CME) by 20.0% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 778,779 shares of the financial services provider’s stock after selling 194,699 shares during the quarter. Bessemer Group Inc. owned approximately 0.22% of CME Group worth $151,171,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. FMR LLC grew its holdings in CME Group by 5.7% during the 1st quarter. FMR LLC now owns 6,553,654 shares of the financial services provider’s stock worth $1,078,600,000 after acquiring an additional 355,566 shares in the last quarter. Janus Henderson Group PLC grew its holdings in CME Group by 10.7% during the 1st quarter. Janus Henderson Group PLC now owns 6,229,661 shares of the financial services provider’s stock worth $1,025,278,000 after acquiring an additional 603,645 shares in the last quarter. Geode Capital Management LLC grew its holdings in CME Group by 12.9% during the 4th quarter. Geode Capital Management LLC now owns 4,715,269 shares of the financial services provider’s stock worth $885,776,000 after acquiring an additional 537,917 shares in the last quarter. Northern Trust Corp grew its holdings in CME Group by 1.0% during the 1st quarter. Northern Trust Corp now owns 4,212,490 shares of the financial services provider’s stock worth $693,291,000 after acquiring an additional 42,753 shares in the last quarter. Finally, Fiera Capital Corp grew its holdings in CME Group by 7.2% during the 1st quarter. Fiera Capital Corp now owns 2,531,242 shares of the financial services provider’s stock worth $416,592,000 after acquiring an additional 169,830 shares in the last quarter. Hedge funds and other institutional investors own 85.72% of the company’s stock.
Shares of CME stock traded down $2.02 during midday trading on Friday, reaching $211.22. 1,257,705 shares of the company were exchanged, compared to its average volume of 1,342,990. CME Group Inc has a 12 month low of $161.05 and a 12 month high of $217.65. The company has a market cap of $76.36 billion, a P/E ratio of 30.97, a PEG ratio of 4.75 and a beta of 0.23. The company’s 50 day moving average price is $206.79 and its two-hundred day moving average price is $187.33. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.05 and a current ratio of 1.05.
CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.76 EPS for the quarter, topping analysts’ consensus estimates of $1.75 by $0.01. CME Group had a net margin of 39.36% and a return on equity of 9.14%. The company had revenue of $1.27 billion for the quarter, compared to the consensus estimate of $1.27 billion. During the same period in the previous year, the firm earned $1.74 EPS. CME Group’s revenue was up 20.1% on a year-over-year basis. As a group, sell-side analysts predict that CME Group Inc will post 6.68 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Tuesday, September 10th will be issued a $0.75 dividend. The ex-dividend date of this dividend is Monday, September 9th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.42%. CME Group’s payout ratio is currently 43.99%.
Several research analysts have recently commented on CME shares. Barclays lifted their price target on shares of CME Group from $191.00 to $197.00 and gave the company an “overweight” rating in a report on Thursday, May 23rd. Deutsche Bank lifted their price target on shares of CME Group from $224.00 to $240.00 and gave the company a “buy” rating in a report on Friday, August 9th. Zacks Investment Research lowered shares of CME Group from a “hold” rating to a “sell” rating and set a $158.00 price target for the company. in a report on Monday, May 27th. ValuEngine raised shares of CME Group from a “hold” rating to a “buy” rating in a report on Wednesday, May 8th. Finally, Citigroup set a $202.00 target price on shares of CME Group and gave the company a “buy” rating in a research note on Thursday, May 2nd. Three investment analysts have rated the stock with a sell rating, five have issued a hold rating and eight have issued a buy rating to the company. The stock presently has an average rating of “Hold” and an average target price of $194.00.
In other news, insider Sunil Cutinho sold 1,990 shares of CME Group stock in a transaction that occurred on Tuesday, August 6th. The shares were sold at an average price of $202.38, for a total value of $402,736.20. Following the transaction, the insider now directly owns 31,182 shares of the company’s stock, valued at $6,310,613.16. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Dennis Suskind sold 1,500 shares of the business’s stock in a transaction that occurred on Friday, August 9th. The shares were sold at an average price of $212.46, for a total transaction of $318,690.00. Following the transaction, the director now directly owns 4,853 shares in the company, valued at $1,031,068.38. The disclosure for this sale can be found here. Insiders sold a total of 76,271 shares of company stock worth $15,290,370 over the last quarter. Insiders own 1.20% of the company’s stock.
About CME Group
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
See Also: Outstanding Shares
Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.